# Elevated neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in peripheral blood are associated with higher risk of atherosclerotic renal artery stenosis

**Authors:** Min Lei, Zhile Li, Hong Ling, Xiaojie Wang, Yuping Wu, Guoqiang Zhong, Ge Xu

PMC · DOI: 10.3389/fcvm.2026.1737606 · Frontiers in Cardiovascular Medicine · 2026-02-19

## TL;DR

High levels of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in blood are linked to a higher risk and severity of atherosclerotic renal artery stenosis (ARAS), suggesting they could be useful diagnostic indicators.

## Contribution

This study identifies NLR and PLR as novel potential biomarkers for diagnosing and assessing severity of atherosclerotic renal artery stenosis.

## Key findings

- NLR and PLR levels are elevated in patients with atherosclerotic renal artery stenosis (ARAS) and increase with stenosis severity.
- PLR independently predicts ARAS risk, while NLR shows a nonlinear threshold effect at 3.56.
- Combining NLR and PLR with age and serum creatinine improves diagnostic accuracy for ARAS.

## Abstract

The prevalence of atherosclerotic renal artery stenosis (ARAS) has been steadily increasing, yet reliable non-invasive diagnostic methods are lacking. This study investigated the association of platelet to lymphocyte ratio (PLR) and neutrophil to lymphocyte ratio (NLR) with atherosclerotic renal artery stenosis (ARAS).

Data were collected from a total of 1,026 patients, including 362 with ARAS and 664 without. RCS, Logistic regression analysis and stratified analysis were conducted to identify significant risk factors. The diagnostic value of PLR and NLR in predicting the occurrence and severity of ARAS was evaluated using receiver operating characteristic curve analysis.

NLR and PLR were elevated in ARAS patients and increased with stenosis severity (NLR r = 0.83). NLR exhibited a nonlinear threshold effect at 3.56, with stronger associations below this cutoff. PLR independently predicted ARAS risk (OR 1.009, p < 0.001). ROC analysis showed moderate diagnostic performance, which improved when NLR and PLR were combined with age and serum creatinine (AUC 0.711). In subgroup analyzes, NLR association was amplified in renal impairment, while PLR interaction was significant only in the overweight/obese group.

Elevated levels of NLR and PLR are associated with an increased risk of developing ARAS. Moreover, a higher NLR is linked to more severe stenosis in ARAS cases. Therefore, NLR and PLR have the potential to serve as novel indicators for diagnosing ARAS.

## Full-text entities

- **Genes:** CST3 (cystatin C) [NCBI Gene 1471] {aka ADLDWA, ARMD11, HEL-S-2}, CYGB (cytoglobin) [NCBI Gene 114757] {aka HGB, NOD, STAP}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, LPA (lipoprotein(a)) [NCBI Gene 4018] {aka AK38, APOA, LP}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** insufficiency (MESH:D000309), malignancies (MESH:D009369), calcification (MESH:D002114), diabetes (MESH:D003920), lymphopenia (MESH:D008231), impairment (MESH:D060825), renal failure (MESH:D051437), 4 chronic kidney disease (MESH:D051436), fibromuscular dysplasia (MESH:D005352), hepatic insufficiency (MESH:D048550), NLR (MESH:D015467), Hyperlipidemia (MESH:D006949), inflammation (MESH:D007249), HL (MESH:C538324), Takayasu arteritis (MESH:D013625), proteinuria (MESH:D011507), renal ischemia (MESH:D007511), Stenosis (MESH:D003251), renal vascular hypertension (MESH:D006977), obese (MESH:D009765), cardiac and cerebral atherosclerosis (MESH:D002537), deterioration of renal function (MESH:D058186), Overweight (MESH:D050177), ischemic stroke (MESH:D002544), acute or chronic infections (MESH:D054198), end-stage renal disease (MESH:D007676), ARAS (MESH:D012078), Cardiovascular diseases (MESH:D002318), acute myocardial infarction (MESH:D009203), thrombosis (MESH:D013927), renal microvascular injury (MESH:D017566), renal anemia (MESH:D000740), AS (MESH:D050197), malnutrition (MESH:D044342), occlusion of the renal artery (MESH:D001157), Hypertension (MESH:D006973), hematological disorders (MESH:D006402), RCS (MESH:D002313), atheroma (MESH:D058226), immune dysregulation (OMIM:614878), Hypertriglyceridemia (MESH:D015228), endothelial (MESH:D005642), ischemic nephropathy (MESH:D007674), congestive heart failure (MESH:D006333), peripheral artery disease (MESH:D058729), Type 2 Diabetes (MESH:D003924), tuberculosis (MESH:D014376)
- **Chemicals:** UA (MESH:D014527), TG (MESH:D014280), blood glucose (MESH:D001786), cholesterol (MESH:D002784), Scr (-), reactive oxygen species (MESH:D017382), creatinine (MESH:D003404), steroids (MESH:D013256), lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12960576/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12960576/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC12960576/full.md

---
Source: https://tomesphere.com/paper/PMC12960576